

There is a conversation that happens in healthcare practices more often than it should. Month-end arrives. Collections come in. They are lower than expected. And within hours, the billing team is defending itself.
This happens not because billing teams are performing poorly. It happens because no verified expectation was set at the beginning of the month. Without a reliable forecast, every shortfall becomes a disagreement. The practice believes more should have been collected. The billing team believes the numbers reflect what was actually collectible. Both may be right – but no one has the data to prove it either way.
This is the problem that revenue cycle forecasting solves. Not by predicting the future perfectly, but by establishing a documented, data-driven expectation that both sides can hold each other accountable to.
The majority of billing operations produce some version of a monthly collections estimate. But an estimate generated without systematic methodology is not a forecast – it is a guess with a number attached.
Effective revenue cycle forecasting requires four connected activities working in sequence: identifying revenue leakage, recommending corrective actions, monitoring implementation, and measuring improvement. When those four elements are integrated, a projection is not just a number – it is a living diagnostic that tells you where your revenue cycle is performing, where it is underperforming, and what is being done about it.
Most organizations stop at the first element. They identify what was not collected and stop there. The projection becomes a historical summary rather than a forward-looking instrument.
We run two projection cycles every month, timed to the natural rhythm of the revenue cycle.
BOM projections are completed within the first five business days of each month. They are built from three inputs:
The result is a collective projection shared with both clients and internal management before meaningful collections activity has begun for the month. This number anchors the month. It gives the practice a verified expectation before a single payment has arrived, and it gives our internal teams a performance target to work against from day one.
MOM projections are calculated between the 15th and 20th of the month. By this point, we have two additional weeks of data to work with. The MOM projection incorporates:
The MOM projection is the more precise of the two. At this point in the month, we have enough data on payer behavior, denial trends, and reimbursement timing to produce a forecast that reflects what the month will actually close at – not what we hoped it would.
Together, BOM and MOM give practice leadership two verified checkpoints every month rather than a single end-of-month surprise.
RCM revenue forecasting without a close-out process is incomplete. The projection is only valuable if it is systematically compared to what actually happened.
At the end of every financial month, once collections are finalized, we perform a projection-versus-collection analysis. We cross-verify every dollar collected against the projected data, identify deviations, and document the reason behind each gap. We call this difference the collection variance.
If collections fall short of the projection, we perform root-cause analysis on why. Was it a payer-specific delay? A denial wave tied to a documentation issue? A bulk action that did not clear in the expected window? Each cause gets a documented response, and that response informs how we refine the following month's projection methodology.
If collections exceed the projection, we analyze that too. Unexpected payments that beat the forecast need to be understood – whether they represent accelerated processing, a large payment for a prior-period balance, or a one-time event that should not be built into next month's baseline.
This close-out process is what transforms healthcare revenue projections from a reporting function into a continuous improvement cycle.
Across our gastroenterology and ambulatory surgery center client portfolios, we have maintained 99%+ accuracy in projection-versus-collection analysis. In clinical pathology, our average accuracy rate is 98%+.
That number is worth examining carefully, because it is easy to mistake what it means.
98%+ accuracy does not mean that we are collecting 98% of what is billed. It means that when we project a collections number at the beginning or middle of a month, actual collections land within 2% of that number – in either direction – 98% or more of the time.
The operational implication of that level of precision is significant:
This is the difference between a billing partner that processes your claims and one that helps you manage your business.
Organizations that do not operate a systematic revenue cycle forecasting model face predictable consequences, and I have seen all of them across 18 years in this field.
The most common is attribution failure. When actual collections consistently lag expectations – without a documented projection methodology to explain why – practices increasingly blame the billing team for outcomes that may have nothing to do with billing performance. A payer that slowed processing by two weeks generates the same end-of-month shortfall as a coder who missed modifiers, but they look identical in a standard collections report. Without a BOM and MOM projection that accounts for payer-specific payment turnaround times and anticipated denial volumes, there is no way to distinguish between them.
The second consequence is credibility erosion. A billing partner that cannot reliably predict what a month will yield is a billing partner that cannot prove its value. In a market where practices are increasingly evaluating their RCM partnerships on measurable outcomes, the inability to forecast with precision is a competitive disadvantage that compounds over time.
The third is internal planning exposure. Without a reliable monthly projection, practice administrators cannot accurately plan staffing, manage cash flow timing, or make capital decisions with confidence. The billing function becomes a variable that management works around rather than an asset it relies on.
In my experience leading revenue cycle operations, the organizations that manage their revenue cycles most effectively are those that treat forecasting as infrastructure, not reporting.
The BOM and MOM projection model is not administratively complex. But it requires discipline, consistent methodology, and a willingness to be held accountable to the numbers you produce. That accountability is what separates a projection from a guess.
When a practice knows, on the first of the month, what it should expect to collect – and knows again on the 15th, updated for everything the first two weeks revealed – it operates differently. It plans with confidence. It identifies problems early enough to address them. And when the month closes, it has the data to understand exactly what happened and why.
The projection analysis is not a forecast in the traditional sense. It is an early warning system – one that, built correctly, makes the end-of-month conversation less about blame and more about what to do differently next time.
That is the standard every RCM revenue forecasting partnership should be held to.
If your current revenue cycle partner cannot tell you on the first of the month what you should expect to collect – and prove it two weeks later – it is worth understanding what a different model looks like. Connect with 3Gen's revenue cycle team.
Thiyagarajan G is an Assistant Vice President of Revenue Cycle at 3Gen Consulting, with 18 years of experience in medical billing services across physician, laboratory, hospital, and dental specialties. He specializes in MAC provider billing, in-network and out-of-network reimbursement, and credentialing – helping U.S. healthcare organizations navigate complex financial, compliance, and technology challenges to drive measurable improvements in revenue performance.
See how 3Gen's dual-projection model delivers 98%+ forecasting accuracy.


The FAQ section simplifies key information about 3Gen Consulting’s services, helping partners navigate our offerings, methodologies, and value.
Revenue cycle forecasting is a systematic methodology for predicting monthly collections based on open AR balances, payer-specific payment timelines, expected denial volumes, and historical reimbursement patterns – verified at the beginning and middle of each month. Standard billing reporting describes what already happened; revenue cycle forecasting establishes a documented expectation before the month's collections activity begins, creating an accountability benchmark for both the billing team and practice leadership.
Beginning of Month (BOM) projections are completed within the first five business days of each month, built from open AR balances, expected revenue from special projects, and anticipated collections from prior-month bulk actions. Mid-Month (MOM) projections are calculated between the 15th and 20th, incorporating first-two-weeks charges, unpaid prior-month balances, average payer payment turnaround times, and expected denial rates – producing a more precise forecast as the month's data matures.
Collection variance is the gap between projected collections and actual collections at month-end, and it is the diagnostic that reveals whether a revenue cycle forecasting model is functioning correctly. When variance exists, root-cause analysis identifies whether the gap traces to payer processing delays, unexpected denial volumes, documentation issues, or one-time payment events – and that analysis informs how the following month's projection methodology is refined.
High-performing revenue cycle forecasting models should sustain projection-versus-collection accuracy above 98% – meaning actual collections consistently land within 2% of the projected number in either direction. At 3Gen Consulting, we maintain 98%+ accuracy across our gastroenterology, ambulatory surgery center, and clinical pathology client portfolios through the BOM and MOM dual-projection methodology combined with monthly close-out variance analysis.
Without a documented forecast, every month-end collections shortfall becomes a disputed attribution problem – the practice believes collections should have been higher, the billing team believes the numbers reflect what was actually collectible, and neither side has verified data to distinguish billing performance from payer behavior. A structured revenue cycle forecasting model eliminates this dynamic by establishing a documented, mutually understood expectation before the month begins.
3Gen operates a dual-projection model – BOM and MOM – that sets verified revenue expectations at two points each month, closes with a projection-versus-collection analysis, and performs root-cause analysis on any collection variance. This model has produced 98%+ forecasting accuracy across gastroenterology, ASC, and clinical pathology clients, transforming revenue projections from a passive reporting function into an active early warning system for practice financial management.